OSR Health (OSRHW) Gross Profit (2024 - 2026)
OSR Health (OSRHW) posted Gross Profit of $160281.0 for Q1 2026, up 23.57% sequentially from $129704.0 in Q4 2025, and down 4.98% YoY from $168685.6 in Q1 2025.
OSR Health (OSRHW) Gross Profit (2024 - 2026) Analysis & Trends
OSR Health has reported Gross Profit for 3 years, with the latest figure at $160281.0 in Q1 2026.
- Quarterly Gross Profit fell 4.98% year-over-year to $160281.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $584501.0 (down 21.03% YoY) and the FY2025 annual result came in at $592905.0, down 26.91% from the prior year.
- Gross Profit improved to $160281.0 in Q1 2026 per OSRHW's latest filing, from $129704.0 in the prior quarter.
- Over five years, Gross Profit peaked at $261734.0 in Q3 2025 and troughed at $32782.0 in Q2 2025.
- A 3-year average of $173824.8 and a median of $168685.6 in 2025 frame the typical range for Gross Profit.
- The widest YoY moves for Gross Profit: up 46.14% in 2025, down 85.89% in 2025.
- Over 3 years, Gross Profit stood at $160021.0 in 2024, then fell by 18.95% to $129704.0 in 2025, then increased by 23.57% to $160281.0 in 2026.
- According to Business Quant data, Gross Profit over the past three periods registered $160281.0, $129704.0, and $261734.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.12 Bn | 131.27 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.30 Bn | 77.31 Bn | 3.93 Bn |
| 3 | Argenx Se | 62.84 Bn | 57.66 Bn | 1.37 Bn |
| 4 | Moderna | 55.67 Bn | 50.53 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.43 Bn | 36.33 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.70 Bn | 28.39 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.47 Bn | 9.08 Bn | 668.28 Mn |
| 8 | Royalty Pharma | 27.16 Bn | 26.33 Bn | - |
| 9 | Insmed | 27.03 Bn | 25.87 Bn | 358.27 Mn |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 160,281.03 |
| Mar 31, 2026 | 160,281.03 |
| Dec 31, 2025 | 129,704.00 |
| Dec 31, 2025 | 129,704.00 |
| Sep 30, 2025 | 261,734.00 |
| Sep 30, 2025 | 261,734.00 |
| Jun 30, 2025 | 32,782.00 |
| Jun 30, 2025 | 32,782.00 |
| Mar 31, 2025 | 168,685.60 |
| Mar 31, 2025 | 168,685.60 |
| Dec 31, 2024 | 160,021.00 |
| Dec 31, 2024 | 160,021.00 |
| Sep 30, 2024 | 179,093.00 |
| Sep 30, 2024 | 179,093.00 |
| Jun 30, 2024 | 232,321.00 |
| Jun 30, 2024 | 232,321.00 |
| Mar 31, 2024 | 239,802.00 |
| Mar 31, 2024 | 239,802.00 |